Trial Profile
A retrospective, observational study to compare outcomes of Adalimumab and Infliximab for patients with ulcerative colitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 21 Aug 2015 New trial record